日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Implementing early rehabilitation and mobilisation for children in UK paediatric intensive care units: the PERMIT feasibility study

在英国儿科重症监护病房实施儿童早期康复和活动:PERMIT可行性研究

Scholefield, Barnaby R; Menzies, Julie C; McAnuff, Jennifer; Thompson, Jacqueline Y; Manning, Joseph C; Feltbower, Richard G; Geary, Michelle; Lockley, Sophie; Morris, Kevin P; Moore, David; Pathan, Nazima; Kirkham, Fenella; Forsyth, Robert; Rapley, Tim

Adaptive therapy achieves long-term control of chemotherapy resistance in high grade ovarian cancer

适应性治疗实现高级别卵巢癌化疗耐药性的长期控制

Helen Hockings, Eszter Lakatos, Weini Huang, Maximilian Mossner, Mohammed Ateeb Khan, Stephen Metcalf, Francesco Nicolini, Kane Smith, Ann-Marie Baker, Trevor A Graham, Michelle Lockley

Carvedilol targets β-arrestins to rewire innate immunity and improve oncolytic adenoviral therapy

卡维地洛靶向 β-抑制蛋白,重塑先天免疫,改善溶瘤腺病毒疗法

Joseph I Hoare, Bleona Osmani, Emily A O'Sullivan, Ashley Browne, Nicola Campbell, Stephen Metcalf, Francesco Nicolini, Jayeta Saxena, Sarah A Martin, Michelle Lockley

Chloroxine overrides DNA damage tolerance to restore platinum sensitivity in high-grade serous ovarian cancer

氯霉素可克服 DNA 损伤耐受性,恢复高级别浆液性卵巢癌的铂敏感性

Vera L Silva, Jayeta Saxena, Francesco Nicolini, Joseph I Hoare, Stephen Metcalf, Sarah A Martin, Michelle Lockley

A human multi-cellular model shows how platelets drive production of diseased extracellular matrix and tissue invasion

人类多细胞模型揭示了血小板如何驱动病变细胞外基质的生成和组织侵袭。

Beatrice Malacrida ,Sam Nichols ,Eleni Maniati ,Roanne Jones ,Robin Delanie-Smith ,Reza Roozitalab ,Eleanor J Tyler ,Morgan Thomas ,Gina Boot ,Jonas Mackerodt ,Michelle Lockley ,Martin M Knight ,Frances R Balkwill ,Oliver M T Pearce

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer

PHLDA1介导受体酪氨酸激酶驱动的癌症的耐药性

Abbie E Fearon, Edward P Carter, Natasha S Clayton, Edmund H Wilkes, Ann-Marie Baker, Ekaterina Kapitonova, Bakhouche A Bakhouche, Yasmine Tanner, Jun Wang, Emanuela Gadaleta, Claude Chelala, Kate M Moore, John F Marshall, Juliette Chupin, Peter Schmid, J Louise Jones, Michelle Lockley, Pedro R Cuti

CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma

CRISPR/Cas9 介导的 Trp53 和 Brca2 敲除可产生改良的卵巢高级别浆液性癌小鼠模型

Josephine Walton, Julianna Blagih, Darren Ennis, Elaine Leung, Suzanne Dowson, Malcolm Farquharson, Laura A Tookman, Clare Orange, Dimitris Athineos, Susan Mason, David Stevenson, Karen Blyth, Douglas Strathdee, Frances R Balkwill, Karen Vousden, Michelle Lockley, Iain A McNeish

RAD51 and BRCA2 Enhance Oncolytic Adenovirus Type 5 Activity in Ovarian Cancer

RAD51 和 BRCA2 增强卵巢癌中溶瘤腺病毒 5 型的活性

Laura A Tookman, Ashley K Browne, Claire M Connell, Gemma Bridge, Carin K Ingemarsdotter, Suzanne Dowson, Atsushi Shibata, Michelle Lockley, Sarah A Martin, Iain A McNeish

Pharmacological Inhibition of β3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity

β3整合素的药理学抑制可降低溶瘤腺病毒引起的炎症毒性,而不会损害抗癌活性

Ashley Browne, Laura A Tookman, Carin K Ingemarsdotter, Russell D Bouwman, Katrina Pirlo, Yaohe Wang, Iain A McNeish, Michelle Lockley